Cargando…

Effects of Vonoprazan on the Antiplatelet Function of Prasugrel Assessed by the VerifyNow P2Y(12) Assay in Patients With Coronary Artery Disease

Background: Vonoprazan is a potassium-competitive acid blocker increasingly used in Japan to prevent upper gastrointestinal bleeding in patients undergoing dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). Cytochrome P450 (CYP) 3A4 is involved in the primary metabolism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koga, Seiji, Ikeda, Satoshi, Akashi, Ryohei, Yonekura, Tsuyoshi, Kawano, Hiroaki, Maemura, Koji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Circulation Society 2020
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939790/ https://www.ncbi.nlm.nih.gov/pubmed/33693287 http://dx.doi.org/10.1253/circrep.CR-20-0124

Ejemplares similares

Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor
por: Angiolillo, Dominick J., et al.
Publicado: (2021)

Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
por: Mshelbwala, Fakilahyel S, et al.
Publicado: (2020)

Change of Platelet Reactivity to Antiplatelet Therapy after Stenting Procedure for Cerebral Artery Stenosis: VerifyNow Antiplatelet Assay before and after Stenting
por: Lee, Deok Hee, et al.
Publicado: (2012)

Periprocedural Variability of Platelet Functions in Carotid Artery Stenting: An Analysis Using VerifyNow
por: Yoshimura, Masataka, et al.
Publicado: (2021)

Investigation of the interaction between proton pump inhibitors and clopidogrel using VerifyNow P2Y12 assay
por: Lin, Sheng-Feng, et al.
Publicado: (2020)

Performance comparison of aspirin assay between Anysis and VerifyNow: Assessment of therapeutic platelet inhibition in patients with cardiac diseases
por: Piao, Jinxiang, et al.
Publicado: (2021)

Comparison of VerifyNow, thromboelastography, and PL-12 in patients with minor ischemic stroke or transient ischemic attack
por: Ma, Lin, et al.
Publicado: (2021)

Different Influences of Hematocrit on the Results of Two Point-Of-Care Platelet Function Tests, the VerifyNow Assay and Multiple Electrode Platelet Aggregometry
por: Kim, Yun Gi, et al.
Publicado: (2014)

Vasospastic Angina: An Immune-related Adverse Event
por: Kumamoto, Taku, et al.
Publicado: (2021)

Clopidogrel non-responsiveness in patients undergoing percutaneous coronary intervention using the VerifyNow test: frequency and predictors
por: Yaseen, Israa Fadhil, et al.
Publicado: (2019)

Blood loss after coronary artery bypass by aspirin responsiveness assessed with preoperative VerifyNow aspirin testing
por: Willemsen, Laura M., et al.
Publicado: (2021)

The optimal threshold of high post-treatment platelet reactivity could be defined by a point-of-care VerifyNow P2Y12 assay
por: Jeong, Young-Hoon, et al.
Publicado: (2008)

Application of Auxiliary VerifyNow Point-of-Care Assays to Assess the Pharmacodynamics of RUC-4, a Novel αIIbβ3 Receptor Antagonist
por: Bentur, Ohad S., et al.
Publicado: (2021)

Calciphylaxis Diagnosed on Skin Biopsy in a Patient With Left Posterior Tibial Artery Stenosis
por: Kuwasaki, Shigeki, et al.
Publicado: (2019)

Fulminant Myocarditis 24 Days after Coronavirus Disease Messenger Ribonucleic Acid Vaccination
por: Kawano, Hiroaki, et al.
Publicado: (2022)

Acute thrombosis of everolimus-eluting platinum chromium stent caused by impaired prasugrel metabolism due to cytochrome P450 enzyme 2B6*2 (C64T) polymorphism: a case report
por: Yamagata, Yuki, et al.
Publicado: (2020)

The Relationship between Circulating Polyunsaturated Fatty Acid Levels and Exercise Responses of Patients with Non-ischemic Heart Failure
por: Izumida, Seiya, et al.
Publicado: (2019)

Comparison of Effectiveness and Safety Among 3 Direct Oral Anticoagulants in Patients With Venous Thromboembolism　― A Single-Center Retrospective Study ―
por: Ueno, Yuki, et al.
Publicado: (2022)

Intramyocardial arteriosclerosis with calcification in a patient on haemodialysis due to diabetic nephropathy may not be related to calciphylaxis
por: Kawano, Hiroaki, et al.
Publicado: (2020)

Fulminant Myocarditis and Acute Appendicitis after COVID-19 Vaccination
por: Kawano, Hiroaki, et al.
Publicado: (2022)

Point of Care Tests VerifyNow P2Y12 and INNOVANCE PFA P2Y Compared to Light Transmittance Aggregometry After Fibrinolysis
por: Roule, Vincent, et al.
Publicado: (2018)

Life-threatening Vasospastic Angina Induced by Carteolol Eye Drops
por: Eto, Ryo, et al.
Publicado: (2022)

Delayed Acute Perimyocarditis and Bilateral Facial Nerve Palsy in a Patient with COVID-19
por: Matsumura, Kazuki, et al.
Publicado: (2022)

Comparison of the Brachial-ankle Pulse Wave Velocity between Patients with Acute Coronary Syndrome and Effort Angina Pectoris
por: Yamasa, Toshihiko, et al.
Publicado: (2017)

Aortic Stiffness Is Associated with Coronary Microvascular Dysfunction in Patients with Non-obstructive Coronary Artery Disease
por: Muroya, Takahiro, et al.
Publicado: (2020)

Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview
por: Hillegass, William B, et al.
Publicado: (2011)

Differential impact of diabetes mellitus on antiplatelet effects of prasugrel and clopidogrel
por: Niijima, Satoshi, et al.
Publicado: (2018)

Implications of the Antiplatelet Therapy Gap Left With Discontinuation of Prasugrel in Canada
por: Lordkipanidzé, Marie, et al.
Publicado: (2020)

Comparison of VerifyNow-P2Y(12 )test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy?
por: Godino, Cosmo, et al.
Publicado: (2009)

Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients With Diabetes
por: Alexopoulos, Dimitrios, et al.
Publicado: (2013)

Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases
por: Kiebist, Jan, et al.
Publicado: (2021)

Influence of cytochrome P450 polymorphisms on the antiplatelet effects of prasugrel in patients with non-cardioembolic stroke previously treated with clopidogrel
por: Kitazono, Takanari, et al.
Publicado: (2018)

Antiplatelet Effect of Single Antiplatelet Therapy With Prasugrel and Oral Anticoagulation After Stent Implantation in a Rabbit Arteriovenous Shunt Model
por: Torii, Sho, et al.
Publicado: (2021)

Acute Coronary Syndrome Developed in a 17-year-old Boy with Sitosterolemia Comorbid with Takayasu Arteritis: A Rare Case Report and Review of the Literature
por: Iyama, Keita, et al.
Publicado: (2021)

Cardiac Calcified Amorphous Tumors in a Patient with Hemodialysis for Diabetic Nephropathy
por: Yoshimura, Satoshi, et al.
Publicado: (2017)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
por: Laredo, Viviana, et al.
Publicado: (2020)

CORRIGENDUM: Antiplatelet Effect of Single Antiplatelet Therapy With Prasugrel and Oral Anticoagulation After Stent Implantation in a Rabbit Arteriovenous Shunt Model
por: Torii, Sho, et al.
Publicado: (2022)

Efficacy of vonoprazan for the prevention of bleeding after gastric endoscopic submucosal dissection with continuous use of antiplatelet agents
por: Yoshii, Shunsuke, et al.
Publicado: (2020)

The Histological Features of a Myocardial Biopsy Specimen in a Patient in the Acute Phase of Reversible Catecholamine-induced Cardiomyopathy due to Pheochromocytoma
por: Miura, Miyuki, et al.
Publicado: (2017)

Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI
por: Ki, You-Jeong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a7ikggdjn42hft4f9lqjbr61rp